Denali Therapeutics (DNLI) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

DNLI is expected to report earnings to rise 4.51% to -61 cents per share on October 31

Denali Therapeutics DNLI Stock Earnings Reports

Q3'24

Est.

$-0.62

Q2'24

Beat

by $0.08

Q1'24

Beat

by $0.02

Q4'23

Missed

by $0.06

Q3'23

Beat

by $0.09

The last earnings report on August 01 showed earnings per share of -58 cents, beating the estimate of -67 cents. With 389.78K shares outstanding, the current market capitalization sits at 4.21B.

View a ticker or compare two or three

Compare

DNLI

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For DNLI
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for DNLI (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a biotechnology company

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

161 Oyster Point Boulevard

Phone

+1 650 866-8548

Employees

445

Web

https://www.denalitherapeutics.com